Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Conference News ESC 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

Todd Neale

September 06, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Conference News ESC 2023

FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF

Shelley Wood

August 28, 2023

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Todd Neale

May 18, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

Apixaban Again Linked to Less Bleeding in AF Patients

Michael O'Riordan

October 31, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Conference News HRS 2022

Racial/Ethnic Disparities in Anticoagulation Persist in Hospitalized AF Patients

Todd Neale

April 29, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for October 2021

Shelley Wood

November 02, 2021

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2021

Shelley Wood

September 03, 2021

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2025

TCTMD’s Top 10 Most Popular Stories for November 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

June 2024 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Apixaban Again Linked to Less Bleeding in AF Patients

What’s Going to Be Hot at ESC 2022?

Racial/Ethnic Disparities in Anticoagulation Persist in Hospitalized AF Patients

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

TCTMD’s Top 10 Most Popular Stories for October 2021

October 2021 News Roundup

Long-term Anticoagulation After Unprovoked VTE: New Insights

TCTMD’s Top 10 Most Popular Stories for August 2021

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content